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PTEN is one of the most commonly lost tumor
suppressors in human cancer and is known to inhibit
insulin signaling. Eph receptor tyrosine kinases
(RTKs) have also been implicated in cancer formation
and progression, and they have diverse functions,
including nervous and vascular systemdevelopment.
We show that in C. elegans, the VAB-1 Eph kinase
domain physically interacts with and phosphorylates
PTEN (DAF-18), diminishing its protein levels and
function. vab-1 mutants show increased longevity
and sensitivity to dauer conditions, consistent with
increased DAF-18/PTEN activity and decreased
insulin-like signaling. Moreover, daf-18 mutations
suppress vab-1 oocyte maturation phenotypes inde-
pendent of PI3K signaling. We also present evidence
that DAF-18 has protein phosphatase activity to
antagonize VAB-1 action. Possible implications for
human cancers are discussed, based on the idea that
mutually inhibitory interactions between PTEN and
Eph RTKs may be conserved.
INTRODUCTION
The PTEN (phosphatase and tensin homolog deleted on chro-
mosome ten) tumor suppressor is the second most commonly
mutated tumor suppressor gene (after p53) in human cancers
(Li et al., 1997; Salmena et al., 2008; Steck et al., 1997). Although
mutations that disrupt the PTEN gene are common in cancers,
mutation is not a requirement, as many cancers retain wild-
type copies of the PTEN gene; however, the PTEN protein is
absent from these cells. This suggests that one way PTEN is
regulated is at the level of protein stability. Therefore, deter-
mining how PTEN is regulated at the protein level is crucial to
understanding its role during development and, subsequently,
cancer. PTEN is a dual specificity phosphatase and contains
both lipid and protein phosphatase activities. Whereas the role
of PTEN protein phosphatase is still unclear, it is known that
the predominant lipid phosphatase substrate is PIP3, which
can activate AKT signaling, leading to increased cell migration
and motility. The C. elegans PTEN ortholog is called DAF-18
and has roles in longevity, entry into the dauer larval stage, and
arrest of the cell cycle (Fukuyama et al., 2006; Gil et al., 1999;
Mihaylova et al., 1999; Ogg and Ruvkun, 1998). The humanDevelopPTEN protein can functionally replace DAF-18, suggesting an
evolutionary conserved PTEN signaling pathway in humans
and C. elegans (Solari et al., 2005).
The Eph receptors comprise the largest family of receptor
tyrosine kinases (RTKs) and play various roles in development,
such as embryonic patterning, neuronal targeting, and vascular
development during embryogenesis (for reviews, see Klein,
2004; Kullander and Klein, 2002; Lackmann and Boyd, 2008).
Specific families of Eph RTKs and their ephrin ligands are found
to be overexpressed in various cancer and tumor cell lines, but
their role in cancer is still unclear (Dottori et al., 1999; Merlos-
Sua´rez and Batlle, 2008). C. elegans possesses one Eph RTK,
VAB-1, and its ephrin ligands are required for neuronal signaling
during neural and epidermal morphogenesis (Chin-Sang et al.,
1999, 2002; George et al., 1998; Mohamed and Chin-Sang,
2006). VAB-1/EphR also plays a role in oocyte maturation, nega-
tively regulating Mitogen-activated protein kinase (MAPK) in
developing oocytes (Miller et al., 2003).
Here, we report genetic and physical interactions between
DAF-18/PTEN, and VAB-1/EphR. We show that VAB-1/EphR
negatively regulates DAF-18/PTEN in neurons and oocytes
during development. Our results provide a mechanistic insight
into how these two relatively unrelated proteins function together
in various tissues and processes during C. elegans development
as well as offer provocative hypotheses regarding how these
molecules may be working in higher systems.
RESULTS
VAB-1/EphR Physically Binds DAF-18/PTEN
DAF-18/PTEN was identified as an interacting partner of the
VAB-1 tyrosine kinase domain in a yeast two-hybrid screen.
We screened 3.8 million yeast colonies, and of 55 potential inter-
actions, 5 independent cDNA clones of daf-18/pten were
isolated. Through deletion analysis, we have determined that
a (327aa) region C-terminal to the phosphatase domain is suffi-
cient to bind the VAB-1 tyrosine kinase domain (Figure 1A). To
further confirm the interaction, we expressed GST and MBP
fusions to DAF-18 and VAB-1 in E. coli and showed that they
interact in GST pull-down assays (Figure 1B). A mutation that
abolishes kinase activity (G912E) is still capable of interacting
with DAF-18, indicating that the interaction is kinase indepen-
dent. The full-length DAF-18 did not show an interaction with
VAB-1 in our yeast two-hybrid tests and may explain why a
full-length cDNA was not isolated in our Y2H screens. However,
we showed that full-length DAF-18 can weakly copurify with themental Cell 17, 459–469, October 20, 2009 ª2009 Elsevier Inc. 459
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(C169S or D137A) phosphatase-inactive versions increased its
binding to VAB-1, suggesting that the DAF-18/PTEN phospha-
tase activity may destabilize its binding to VAB-1 (Figure 1C
and data not shown).
VAB-1/EphR and DAF-18/PTEN Are Expressed
in Similar Tissues
To follow up on the DAF-18/PTEN and VAB-1/EphR interaction
and offer the site of function, we asked whether DAF-18/PTEN
and VAB-1/EphR would be localized to similar tissues. Immuno-
histochemistry experiments reveal that DAF-18/PTEN and VAB-
1/EphR are both expressed in the Z2/Z3 germline precursor
cells, oocytes, as well as neuronal tissues (Figure 2). We utilized
two methods to identify DAF-18 expression: endogenous and an
overexpressing daf-18 rescuing line (quIs18). Wild-type animals
show endogenous DAF-18 expression in the germline precursor
cells, Z2/Z3, as well as oocytes (Figures 2B, 2C, and 2G). In our
overexpressing line (quIs18), DAF-18 is also localized to neu-
ronal tissues (2J). VAB-1/EphR is expressed on the membrane
Figure 1. The VAB-1 Tyrosine Kinase
Domain Physically Interacts with DAF-18/
PTEN
(A) Schematic diagram of VAB-1 and the DAF-18/
PTEN full-length protein and other regions tested
for binding to VAB-1. The VAB-1 kinase region
(669– 985aa shown by a dashed box) was used
as bait in yeast two-hybrid assays and identified
five independent clones of the daf-18/pten gene
(last five shown). The full-length DAF-18 protein
does not interact with VAB-1 in yeast two-hybrid
assays. The interaction is strongest within the mid
region of DAF-18 (476–803 aa). The C-terminal
end, which has a predicted PDZ-binding motif
(PDZbm) appeared to reduce the interaction with
VAB-1; relative interaction strength is indicated
by ‘‘+,’’ weak; ‘‘++,’’ medium; ‘‘+++,’’ strong lacZ
activity.
(B) GST pull-down experiments confirm the inter-
action. The VAB-1 kinase domain fused to GST
as well as the VAB-1 kinase-inactive G912E both
show equal binding to MBP::DAF-18. Protein
expression of GST and GST::VAB-1 is shown
below by Coomassie staining.
(C) MBP::DAF-18 full-length copurifies with HIS-
6::VAB-1 (intracellular). The DAF-18 (D137A) phos-
phatase-inactivating mutation increased binding
to VAB-1. Levels of purified HIS-6::VAB-1 are
shown below.
of the proximal oocytes (Figure 2D),
whereas DAF-18/PTEN appears to show
membrane and nuclear expression of
multiple oocytes in both hermaphrodites
and females (Figures 2E–2H). In the
neuronal tissues, VAB-1/EphR is local-
ized to the ventral nerve cord, nerve
ring, and some head neurons (Figure 2I),
whereas (quIs18) DAF-18/PTEN’s neu-
ronal expression is restricted to a subset
of the head amphid neurons and is
expressed weakly in the nerve cord. We also detected DAF-
18::GFP in the amphids and ventral nerve cord (data not shown).
Because of the known interaction with VAB-1/EphR, we asked
whether vab-1 mutants can affect the expression pattern of
DAF-18 protein. Interestingly, we found that DAF-18 expression
is visible in neuronal tissues of vab-1 mutants (Figure 2L), similar
to our overexpressing lines (Figure 2M), whereas endogenous
DAF-18 could not be detected in neurons (Figure 2K). We also
noted that vab-1 increased the strength of expression and the
frequency of nuclear expression in oocytes (2F); 81.6% of
fem-1(hc17);vab-1(dx31) worms had DAF-18/PTEN in nuclei
(n = 60), versus 20.8% of fem-1(hc17) worms (n = 283), further
supporting our suspicion that VAB-1/EphR regulates DAF-18/
PTEN.
VAB-1 Negatively Regulates DAF-18/PTEN
at the Protein Level
To investigate the form of regulation between the DAF-18/PTEN
and VAB-1/EphR interaction, western blots were performed to
look at DAF-18/PTEN protein levels. We were able to detect460 Developmental Cell 17, 459–469, October 20, 2009 ª2009 Elsevier Inc.
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type embryos showed low expression of DAF-18/PTEN,
whereas our overexpressing DAF-18/PTEN line, quIs18, showed
stronger expression (2-fold more). daf-18(ok480) did not have
detectable levels of DAF-18/PTEN protein, suggesting this to
be a null allele. Interestingly, the vab-1(dx31) null and vab-1(e2)
kinase-inactive alleles showed increased DAF-18/PTEN expres-
sion compared to wild-type levels (3-fold more), indicating that
VAB-1/EphR is a negative regulator of DAF-18/PTEN, and that
the kinase activity is required for DAF-18/PTEN regulation
(Figure 3A). To provide further evidence that VAB-1/EphR has
a negative influence on DAF-18 levels, we used an inducible
gain-of-function VAB-1. Experiments with a myristoylated
VAB-1/EphR under a heat-shock promoter (quIs16) showed
that induced VAB-1 can indeed reduce DAF-18 protein levels
(Figure 3B). Additionally, we found that vab-1(dx31) increased
DAF-18 protein in the weak daf-18(e1375) strain (Figure 3C).
RT-PCR experiments showed that daf-18/pten transcript levels
Figure 2. VAB-1 and DAF-18/PTEN Are
Expressed in Similar Tissues
(A–M) VAB-1 and DAF-18 are expressed in the
germline precursor cells (Z2/Z3), oocytes, and
neuronal tissues. (A) VAB-1 expression in Z2/Z3
(comma-stage embryo). (B) DAF-18 expression
in Z2/Z3 (100-cell stage). (C) VAB-1 and DAF-
18 Z2/Z3 expression in L1 larvae. (D) VAB-1 is
expressed in at least two of the proximal oocytes,
whereas (E and G) DAF-18 is expressed in more
than five oocytes in both wild-type and female
animals. (F and H) Increased DAF-18 expression
is observed in fem-1(hc17);vab-1(dx31) mutants,
and nuclear expression is also apparent. (I) VAB-1
is expressed in a variety of neuronal tissues,
whereas (J) DAF-18 expression appears to be
restricted to several of the amphid neurons. (K–
M) DAF-18 protein is not detectable in head
neurons of wild-type (WT) animals, but it is present
in vab-1(dx31) and in the daf-18 overexpressing
line (quIs18).
are not affected in a vab-1(dx31) mutant
background (Figure 3D). Lastly, in vivo
evidence substantiating a negative regu-
lation of DAF-18/PTEN by VAB-1/EphR
shows that DAF-18/PTEN expression is
not detectable in the nervous system of
wild-type L1 larvae, yet is clearly visible
in vab-1(dx31) and our overexpressing
line, quIs18 (Figures 2K–2M). Taken
together, our findings show that VAB-1
negatively regulates DAF-18/PTEN at
the protein level.
Increased DAF-18/PTEN
Expression Confers Increased
Longevity and Sensitivity
to Dauer Larva Conditions
Since inhibition of DAF-2/insulin-like
receptor and AGE-1/PI3K signaling leads
to increased longevity and sensitivity to
dauer conditions, we hypothesized that increased DAF-18/
PTEN expression should show similar results to daf-2 and
age-1 mutants, as DAF-18/PTEN has been shown to reduce
PI3K signaling by dephosphorylation of PIP3 (Solari et al., 2005).
Furthermore, if VAB-1/EphR is a negative regulator of DAF-18/
PTEN, we would expect that vab-1(dx31) might show a similar
phenotype to our overexpressing DAF-18/PTEN animals.
Longevity and dauer larva studies supported our hypothesis
that overexpression of DAF-18/PTEN does lead to increased
life span and sensitivity to dauer conditions (Figure 4). fem-
1(hc17);vab-1(dx31) and fem-1(hc17);quIs18 have significantly
longer life spans than fem-1(hc17) (Figure 4A). The fem-1(hc17)
mutant was used to eliminate the need for daily transfers of
counted worms away from their progeny and does not have an
effect on life span (Glenn et al., 2004). Also consistent with
increased DAF-18 signaling, we found that worms expressing
elevated levels of DAF-18 were more sensitive to dauer condi-
tions than wild-type. vab-1(dx31) and quIs18 formed dauersDevelopmental Cell 17, 459–469, October 20, 2009 ª2009 Elsevier Inc. 461
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Level
(A) Western blot with DAF-18 antibodies detects endogenous DAF-18 protein
in embryo lysates. Wild-type (WT) DAF-18 expression was standardized as
relative intensity 1.0. The daf-18(ok480) appears to be a null allele, as no462 Developmental Cell 17, 459–469, October 20, 2009 ª2009 Elsevmore frequently on daf-2 RNAi at 25C compared to wild-type
(Figure 4B). The increased dauer sensitivity was also observed
in vab-1(dx31) and quIs18 animals at 27C, where vab-1(dx31)
and quIs18 animals formed significantly more dauers than N2
wild-type (N2 = 54%, vab-1(dx31) = 93%, quIs18 = 82%). This
temperature has been shown to induce dauer in some strains
during nonstarvation/noncrowding conditions (Ailion and
Thomas, 2000).
DAF-18/PTEN Functions Downstream
of VAB-1 in Oocyte Maturation
Because DAF-18/PTEN was observed to be expressed in
oocytes (Figure 2G), we questioned whether it may have a role
in oocyte maturation, like VAB-1/EphR (Miller et al., 2001,
2003). We noticed that vab-1(dx31) animals seemed to be laying
a disproportionate number of unfertilized oocytes (Figure 5A). It
has been suggested that vab-1 lays increased numbers of unfer-
tilized oocytes after 60 hr of egg laying and may be due to a lack
of sperm availability (Miller et al., 2003). When we looked at the
total number of oocytes laid over the course of 3 days, we found
that vab-1(dx31) animals laid significantly more unfertilized
oocytes than wild-type animals, and that the daf-18(ok480)
mutation was able to return this phenotype to wild-type levels
(Figure 5B). To test whether VAB-1/EphR is regulating DAF-18/
PTEN through the canonical insulin signaling pathway, we asked
whether mutations in age-1/PI3K would lead to an increased
unfertilized oocyte phenotype, like vab-1 mutants, or whether
daf-16/FOXO could suppress the vab-1 oocyte defect. age-1
(m333) loss-of-function mutants did not show increased oocyte
laying, and, moreover, daf-16(mu86) did not suppress the vab-1
(dx31) increased oocyte laying defect, suggesting that DAF-18/
PTEN functions independent of the insulin signaling pathway in
oocyte maturation (Figure 5D). To determine whether this in-
crease in oocyte laying was only occurring after 60 hr of egg
laying and when the sperm was depleted, we performed
a day-by-day breakdown of unfertilized oocytes laid (Figure 5E).
Our results show that after 24 hr of egg laying, vab-1(dx31)
animals laid significantly more oocytes than vab-1(dx31);daf-18
(ok480) animals; thus, it is not completely due to a depletion of
sperm, as unfertilized embryos are also visible among fertilized
embryos in vab-1(dx31) animals prior to 60 hr of egg laying
(Figure 5C). The laying of increased unfertilized oocytes can be
explained by ovulation rate, as vab-1(dx31) animals have a
protein product is detected (relative intensity 0.34 ± 0.19). daf-18 genomic
rescue (quIs18) (relative intensity 1.69 ± 0.31), vab-1(dx31) (relative intensity
2.87 ± 0.03), and vab-1(e2) (relative intensity 2.45 ± 0.81) show increased
DAF-18 expression compared to wild-type.
(B) Increased VAB-1 signaling reduces DAF-18 expression. A quIs16(a Hs
promoter myr::vab-1);quIs18(daf-18 genomic) double transgenic animal
shows decreased DAF-18 expression (lowered by 15%) under heat-shock
(HS) conditions when VAB-1 is constitutively active (left). DAF-18 expression
is slightly affected (increased by 7%) by heat-shock conditions (right).
(C) daf-18(e1375) forms DAF-18 protein at 15C (relative intensity 1.0), but not
at 25C. In a vab-1(dx31) background, daf-18(e1375) forms a DAF-18 protein
product at both temperatures (relative intensities 1.54 ± 0.24 and 1.70 ±
0.17, respectively).
(D) The regulation of DAF-18 by VAB-1 is not at the transcript level. Wild-type
and vab-1(dx31) have equal daf-18 transcript levels, as determined by RT-PCR
(left). Total RNA level and 28 s and 18 s ribosomal subunits (right).ier Inc.
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(Miller et al., 2003). Furthermore, the daf-18(ok480) mutation
returns the ovulation rate of vab-1(dx31) to near wild-type rates.
As activated MAPK expression has been related to oocyte matu-
ration, with vab-1 mutants displaying increased MAPK expres-
sion, we questioned whether DAF-18/PTEN may have a role in
MAPK regulation during oocyte maturation. Interestingly, anti-
body staining against activated MAPK revealed that expression
was decreased in daf-18/pten mutants (Figure 5G), suggesting
that DAF-18/PTEN may be a positive regulator of MAPK in
oocytes. Additionally, daf-18(ok480) was able to suppress the
increased MAPK expression phenotype observed in vab-1
(dx31) mutants (Figure 5G). These findings provide good genetic
evidence for the interaction between DAF-18/PTEN and VAB-1/
EphR and offer a role for DAF-18/PTEN in oocyte maturation
outside of the DAF-2/insulin receptor-like signaling pathway.
Figure 4. Increased DAF-18/PTEN Expression Confers Increased
Longevity and Sensitivity to Dauer Conditions
(A) vab-1(dx31);fem-1(hc17) and quIs18;fem-1(hc17) have a significantly
longer life span than fem-1(hc17) (p < 0.001). vab-1(dx31);fem-1(hc17) and
quIs18;fem-1(hc17) have mean life spans of 16.39 ± 0.44 days and 18.78 ±
0.45 days (n = 185 and 127, respectively), whereas fem-1(hc17) has a mean
life span of 14.31 ± 0.32 days (n = 137). Data are represented as mean ± Stan-
dard Error of the Mean (SEM).
(B) vab-1(dx31) and quIs18 formed significantly more dauer larva than wild-
type on daf-2 RNAi (*p < 0.01). A total of 14.01% ± 1.02% of vab-1(dx31)
(n = 1577) and 45.0% ± 2.371% (n = 1102) of quIs18 formed dauer larva on
daf-2 RNAi at 25C compared to 4.95% ± 0.66% of wild-type (n = 1778).DevelopDAF-18/PTEN and the VAB-1/EphR Are Substrates
for Each Other
How does VAB-1 exert its negative influence on DAF-18/PTEN?
One possibility is that the VAB-1/Eph receptor tyrosine kinase
may phosphorylate DAF-18/PTEN. To test whether VAB-1 can
phosphorylate DAF-18/PTEN, we coexpressed both proteins in
E. coli and probed with the phosphotyrosine (PY)-specific anti-
body 4G10. Indeed, VAB-1 could specifically phosphorylate
the binding region of DAF-18/PTEN, and this phosphorylation
is kinase dependent (Figure 6A, lanes 1 and 3). In contrast,
VAB-1 did not have tyrosine kinase activity on full-length
DAF-18 protein. We also noticed that the autophosphorylation
level of VAB-1 is reduced greatly when full-length DAF-18 is
coexpressed with VAB-1, indicating that DAF-18 may have tyro-
sine phosphatase activity on VAB-1 (Figure 6A, lane 2). To test
this idea, we used a site-directed mutagenesis approach to
make DAF-18 phosphatase-inactive versions: DAF-18 (C169S)
and DAF-18 (D137A). The DAF-18 (C169S) mutation is analo-
gous to the human PTEN (C124S) and abolishes lipid and protein
phosphatase activity (Myers et al., 1998; Tamura et al., 1998),
whereas the DAF-18 (D137A) mutation is analogous to PTEN
(D92A), which reduces the protein-tyrosine phosphatase, but
retains its ability to bind substrates (also known as ‘‘phosphatase
trap’’) (Tamura et al., 1999). Indeed, the DAF-18 (C169S) and
DAF-18 (D137A) (not shown) phosphatase-deficient proteins
did not reduce the VAB-1 autophosphorylation levels to that
caused by wild-type DAF-18, suggesting that DAF-18 does
have VAB-1 protein tyrosine phosphatase activity (Figure 6A).
To provide in vivo evidence for DAF-18/PTEN tyrosine phospha-
tase activity, we showed that DAF-18 can reduce VAB-1 tyrosine
kinase activity in C. elegans neurons. Mohamed and Chin-Sang
(2006) previously showed that a hyperactive tyrosine kinase
version of VAB-1 (MYR-VAB-1) expressed from the mec-4
promoter caused strong PY levels in the touch (mechanosen-
sory) neurons (Figure 6C). The increased VAB-1 kinase activity
caused neuronal defects, including premature axon termination
defects (Mohamed and Chin-Sang, 2006). Note that the touch
neurons do not stain for PY in wild-type worms, and that PY
detection is dependent on the MYR-VAB-1 tyrosine kinase
activity (Figure 6D). We reasoned that if DAF-18 has tyrosine
phosphatase activity on VAB-1, then it would reduce MYR-
VAB-1 PY levels. When we expressed mec-4::DAF-18 specifi-
cally in the touch neurons, we found that the majority of animals
expressing DAF-18 (23 out of 40) caused a dramatic decrease in
MYR-VAB-1-induced PY (Figure 6E). In addition, the expression
of DAF-18 was able to partially suppress the neuronal defects
caused by MYR-VAB-1. Full suppression was not expected, as
overexpression of DAF-18 in the touch neurons also displayed
neuronal defects (Figure 6F and data not shown). In other cases,
MYR-VAB-1 tyrosine kinase activity still persisted in neurons,
even though the animals carried the mec-4::DAF-18 transgene.
The levels of DAF-18 protein in these neurons, however, were
much lower, suggesting that constitutively active MYR-VAB-1
could downregulate DAF-18 protein in neurons (Figures 6H–
6J). The fact that the kinase-inactive vab-1(e2) allele had similar
effects on increasing the DAF-18/PTEN protein levels (Figure 3A)
provides in vivo evidence that the kinase activity of VAB-1 is
indeed required for regulating the levels of DAF-18/PTEN. Taken
together, our results suggest that the DAF-18/PTEN tyrosinemental Cell 17, 459–469, October 20, 2009 ª2009 Elsevier Inc. 463
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Oocyte Maturation with VAB-1
(A and B) daf-18(ok480) suppresses vab-1(dx31)
oocyte defects. The increased number of unfertil-
ized oocytes laid by vab-1(dx31) compared to
vab-1(dx31);daf-18(ok480) after 48 hr of egg laying
(green signifies a fertilized embryo; red signifies an
unfertilized oocyte).
(C) Unfertilized oocytes are present among fertil-
ized embryos in vab-1(dx31) worms (indicated by
a white arrowhead).
(D) Over a 72 hr egg-laying period, vab-1(dx31)
lays significantly more unfertilized oocytes than
wild-type, daf-18(ok480), vab-1(dx31);daf-18
(ok480), and age-1(m333) (*p < 0.01) (n = 5976,
1426, 3224, 3645, and 4474, respectively). vab-1
(dx31);daf-16(mu86) does not display significant
suppression of the increased oocyte-laying
phenotype (n = 2258).
(E) A day-by-day breakdown of laid objects
reveals that vab-1(dx31) lays significantly more
unfertilized oocytes than vab-1(dx31);daf-18(ok480)
after 24 hr of egg laying (*p < 0.05) (Day 1: vab-1
(dx31), n = 2996; vab-1(dx31);daf-18(ok480),
n = 1600; Day 2: vab-1(dx31), n = 2300; vab-1(dx31);
daf-18(ok480), n = 1130; Day 3: vab-1(dx31),
n = 1864; vab-1(dx31);daf-18(ok480), n = 915.
(F) The daf-18(ok480) mutation suppresses the
increased ovulation rate (number of ovulations/
hour) of vab-1(dx31) (*p < 0.01). Data are repre-
sented as mean ± SEM (WT, n = 19; daf-18
(ok480), n = 14; vab-1(dx31), n = 18; vab-1
(dx31;daf-18(ok480), n = 24).
(G) daf-18(ok480) mutants can suppress vab-1
(dx31)-activated MAPK expression. Activated
MAPK (green) is expressed in upwards of 5 oocytes
invab-1(dx31)worms and in typically 1–3oocytes of
wild-type. In daf-18(ok480) and vab-1(dx31);daf-
18(ok480) mutants, this expression is reduced to
the two most proximal oocytes.phosphatase and the VAB-1 tyrosine kinase can act as
substrates for each protein to inhibit each other’s activity.
DISCUSSION
We show that the C. elegans Eph RTK VAB-1/EphR binds to and
phosphorylates DAF-18/PTEN. DAF-18/PTEN also exhibits
protein phosphatase activity on VAB-1. We provide genetic
evidence that VAB-1 has a negative influence on DAF-18/
PTEN protein levels, leading to increased insulin-like signaling.
In addition, DAF-18/PTEN has a role in oocyte maturation down-
stream of VAB-1/EphR signaling independent of AGE-1/PI3K
signaling.
VAB-1/EphR Negatively Regulates DAF-18/PTEN
at the Protein Level
DAF-18 and PTEN both inhibit the insulin/PI3K signaling
pathway, leading to the inhibition of AKT phosphorylation of
the FOXO transcription factor, and, accordingly, are involved in464 Developmental Cell 17, 459–469, October 20, 2009 ª2009 Elsedauer formation and longevity in C. elegans and in tumor
suppression and apoptosis in mammalian cells (Di Cristofano
and Pandolfi, 2000; Gil et al., 1999; Mihaylova et al., 1999; Ogg
and Ruvkun, 1998; Pinkston et al., 2006). We provide multiple
lines of in vitro and in vivo evidence that show VAB-1/EphR as
a negative regulator of DAF-18/PTEN in C. elegans. DAF-18/
PTEN protein is upregulated in vab-1 mutants and is reduced
by constitutively active VAB-1/EphR signaling. Increased dauer
sensitivity and life span are consistent, with increased DAF-18/
PTEN observed in vab-1 mutants. Phosphorylation of PTEN is
believed to keep it in an inactive state, in which it cannot bind
to PDZ domain proteins (Vazquez et al., 2000, 2001). Similarly,
in our model (Figure 7A), VAB-1/EphR phosphorylates DAF-18/
PTEN, deactivating it, resulting in increased insulin signaling.
An ‘‘electrostatic switch’’ model of phosphorylation/dephos-
phorylation of PTEN’s C-terminal region has been proposed
as a mechanism of recruiting and activating PTEN at the cell
membrane (Das et al., 2003). Although PTEN phosphorylation/
dephosphorylation typically occurs on serine/threoninevier Inc.
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Eph RTK Regulates PTENFigure 6. The VAB-1 Tyrosine Kinase and
the DAF-18 Phosphatase Are Substrates
for Each Other
(A) VAB-1 and DAF-18 MBP fusion proteins were
coexpressed in E. coli. Tyrosine phosphorylation
(PY) was assayed with the anti-phosphotyrosine
(4G10) antibody on western blots. VAB-1 intracel-
lular (581–1117 aa) was able to phosphorylate the
binding fragment of DAF-18 (406–835 aa) (lane 1).
VAB-1 also displays strong autophosphorylation
(autophos.), and coexpression of full-length DAF-
18 full-length reduces VAB-1autophosphorylation
(lane 2). A kinase-inactive VAB-1 (G912E) does
not phosphorylate DAF-18 (406–835 aa) (lane 3).
A phosphatase-deficient DAF-18 (C169S) did not
reduce VAB-1 autophosphorylation as much as
wild-type DAF-18 (compare VAB-1 autophosphor-
ylation levels, in lanes 2 and 4). The blot was strip-
ped and reprobed to show relative quantities of
VAB-1and DAF-18 proteins (below).
(B–G) DAF-18 has tyrosine phosphatase activity
in vivo. (B) Schematic diagram of the C. elegans
six touch neurons (only ALMs and PLMs are
labeled), and boxed regions indicate the regions
shown in the confocal projections below. (C) A
constitutively active VAB-1 tyrosine kinase (MYR-
VAB-1) expressed from the mec-4 promoter
shows strong anti-phosphotyrosine (a-PY) stain-
ing (red) in the touch neurons. MYR-VAB-1 causes
neuronal defects such as premature termination
neuron defects (e.g., PLM truncated). (D) In
wild-type animals, the touch neurons do not
stain for PY, but endogenous PY can be detected
in the gut epithelial cells (asterisk). (E) DAF-18
expressed in the touch neurons reduces MYR-
VAB-1-induced PY (red). Arrows point to the
position of one PLM and one ALM, showing the
absence of PY in these neurons. DAF-18 expres-
sion in the touch neurons had no effect on the
endogenous gut PY (asterisk). (F) The same
worm in (E) stained for DAF-18 (green) showing strong DAF-18 expression in the touch neurons. Expression of DAF-18 could also partially rescue the premature
termination defects (compare the length of PLM in [C] versus [F]). (G) A merged image of (E) and (F).
(H and I) In some neurons, overexpression of DAF-18 was not able to reduce MYR-VAB-1 PY levels, and, instead, the MYR-VAB-1-expressing neuron had the
effect of reducing the DAF-18/PTEN protein level in that neuron. Arrow points to the right ALM, showing high MYR-VAB-1 activity (red) but low DAF-18 protein
(green).residues, our work on DAF-18 tyrosine phosphorylation provides
another mode of regulation for PTEN. Our work on an Eph RTK
also supports previous in vitro work that suggested Src kinases
may have a tyrosine phosphorylation-induced degradation of
PTEN, and this may contribute to the effects of Src on tumorgen-
esis (Lu et al., 2003). However, the regulation of PTEN by tyrosine
phosphorylation is complex, as the Rak tyrosine kinase (a mem-
ber of the Src tyrosine kinase family) can phosphorylate PTEN to
protect it from ubiquitin-mediated degradation (Yim et al., 2009).
These opposing activities of PTEN tyrosine phosphorylation
highlight the need for further work on other tyrosine kinases
and their specific effects on PTEN protein stability. We also
show that, in neurons, DAF-18/PTEN has tyrosine phosphatase
activity on the VAB-1/EphR, reducing its forward signaling. This
protein tyrosine phosphatase activity is reminiscent of reports
that suggested that the platelet-derived growth factor receptor
(an RTK) is inactivated by PTEN tyrosine phosphatase activity
(Mahimainathan and Choudhury, 2004), and that the PTEN tyro-
sine phosphatase activity can also inhibit FAK tyrosine phos-Developphorylation (Tamura et al., 1998). A common theme is emerging
that PTEN tyrosine phosphatase activity may have inhibitory
roles on specific tyrosine kinases.
The Localization of VAB-1/EphR and DAF-18/PTEN
Gives Insight into Their Function in C. elegans
The presence of DAF-18/PTEN in the amphid neurons is
intriguing, as they represent the sensory organs of C. elegans,
allowing for detection of changes in the external environment
(Ashton et al., 1999). In particular, the ADF and ASI amphid
neurons function to control entry into dauer (Perkins et al.,
1986). As such, it is likely that DAF-18 is expressed in at least
these two amphid neurons. DAF-18 is also reported to function
with DAF-2 and AGE-1 in ASER to regulate salt chemotaxis (To-
mioka et al., 2006). Although VAB-1’s neural expression is not
restricted to the amphid neurons, it is known to be present in
nervous tissues (Chin-Sang et al., 1999; George et al., 1998)
and is consistent with regulating DAF-18/PTEN in the amphid
subset of head neurons.mental Cell 17, 459–469, October 20, 2009 ª2009 Elsevier Inc. 465
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VAB-1 Interaction for Regulation of Dauer/
Life Span and Oocyte Maturation in
C. elegans
(A) In neurons, VAB-1/EphR increases insulin
signaling by inhibiting the action of DAF-18/PTEN
on PIP3. In this manner, the AGE-1/PI3K kinase
is not antagonized by DAF-18/PTEN activity,
resulting in increased PIP3 and inhibition of the
DAF-16/FOXO transcription factor responsible
for the initiation of genes involved in life span and
dauer formation.
(B) In oocytes, VAB-1/EphR receives a signal for
oocyte maturation (MSP, major sperm proteins).
In the absence of MSP, VAB-1/EphR acts to inhibit
DAF-18/PTEN activity on MAPK. In the absence of
VAB-1, DAF-18 signaling can positively regulate
MAPK expression, resulting in increased oocyte
maturation.Interestingly, we found that DAF-18 nuclear expression was
more apparent in a vab-1(dx31) background. Whereas there
has not been a published role for nuclear DAF-18, PTEN has
been shown to have some nuclear function, such as forming a
nuclear complex with p53, increasing the transcriptional activity
of p53, and having nuclear effects independent of phosphatase
activity (Freeman et al., 2003). As VAB-1/EphR is a transmem-
brane receptor, it could be that VAB-1/EphR sequesters
DAF-18/PTEN to the membrane, whereas in the absence of
VAB-1/EphR, localization to the nucleus is more permissible.
PTEN cellular function has been found to be dependent on its
localization; cytoplasmic PTEN is primarily involved in AKT-
mediated pathways associated with apoptosis, whereas nuclear
PTEN is AKT independent and induces G0-G1 cell cycle arrest
(Chung et al., 2006; Liu et al., 2005).
The DAF-18/PTEN and VAB-1/EphR Interaction
Introduces Developmental Roles for Eph Receptor
Signaling in C. elegans
Our analysis of the DAF-18/PTEN and VAB-1/EphR interaction
proposes other functions for each protein in C. elegans. By iden-
tifying VAB-1/EphR as a negative regulator of DAF-18/PTEN, we
have placed an Eph receptor as a potential modifier of insulin
signaling, controlling longevity and entry into dauer (Figure 7A).
The vertebrate EphA-ephrinA bidirectional signaling has been
implicated in modulating insulin secretion from b-cell pancreatic
islets; forward EphA5 signaling inhibits insulin secretion,
whereas reverse ephrinA5 signaling stimulates insulin secretion
in response to glucose (Konstantinova et al., 2007). Our results
in C. elegans show an Eph receptor having positive influence
on insulin signaling through downregulation of DAF-18/PTEN
and are consistent with a negative-feedback mechanism
whereby increased insulin signaling reduces insulin secretion.
In C. elegans, oocytes are held in meiotic arrest prior to fertil-
ization, upon which a sequence of signaling events for oocyte
maturation occurs, initiated by binding of the Major Sperm
Protein (MSP) to the VAB-1/EphR (Miller et al., 2001, 2003;
McCarter et al., 1997). In the absence of vab-1, oocyte matura-
tion is deregulated, leading to increased ovulation and MAPK
activation in multiple oocytes (Corrigan et al., 2005; Miller
et al., 2003). Our observation that daf-18/pten can rescue the466 Developmental Cell 17, 459–469, October 20, 2009 ª2009 Elsevoocyte maturation defects displayed by vab-1/EphR gives
DAF-18/PTEN a role in this developmental process downstream
of VAB-1/EphR. Since age-1 mutant animals do not show
increased oocyte maturation, and daf-16 mutants do not sup-
press vab-1’s oocyte defects, we have thus placed DAF-18
between VAB-1 and MAPK in the pathway initiating oocyte
maturation and independent of the canonical insulin pathway
(Figure 7B). Interestingly, Reddy et al. (2008) reported a role for
PTEN function in mammalian oocytes, during follicle activation.
However, overexpressing PI3K or AKT in oocytes does not affect
follicular development or oocyte maturation, suggesting that
PTEN has a stage-specific function or it functions in a PI3K-inde-
pendent manner during mammalian oocyte maturation (Jagarla-
mudi et al., 2009). Previous work in C. elegans has implicated
daf-18 in oocyte maturation, as mutations in daf-18/pten
enhance the endomitotic phenotype of ceh-18, a POU-class,
homeodomain-containing transcription factor that regulates
gonadal sheath differentiation (Suzuki and Han, 2006). Suzuki
and Han postulated that daf-18 may act with ceh-18 to regulate
ovulation to inhibit MAPK. They suggest that DAF-18 may have
a negative influence on MAPK expression through PIP2:PIP3
ratios or the AKT kinases. Although their proposed model of
DAF-18 action in oocytes varies from ours, differences in how
the experiments were done may account for the disparity
between the results. Suzuki and Han used worms that were
starved as L1s and analyzed unmated females, and vab-1
RNAi was used instead of vab-1 mutants. The differences in
MAPK activity in females versus hermaphrodites could account
for the differences in activated MAPK in daf-18 mutants. Indeed,
it was reported previously that the activated MAPK is not
increased in vab-1 females, and the oocyte maturation defect
seen in vab-1 mutants is only present in hermaphrodites or
when sperm protein is introduced to females (Miller et al., 2003).
Therefore, in our analysis, we used hermaphrodites (sperm
present) to specifically look at the levels of activated MAPK in
vab-1 and vab-1;daf-18 doubles. While it may be counterintuitive
to consider DAF-18/PTEN a positive regulator of MAPK based
on the traditional holding that PTEN attenuates MAPK activity
(Chung et al., 2006; Mahimainathan and Choudhury, 2004;
Weng et al., 2002), it does corroborate our model for the VAB-1/
EphR interaction and account for the reduced ovulation ratesier Inc.
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animals. The result that DAF-18/PTEN may function as a positive
regulator of MAPK in C. elegans oocytes is also supported by
other work. Shen and colleagues report that upregulation of
PTEN is associated with increased p38 MAPK activity during
stress-induced inhibition of insulin signaling and may account
for the insulin resistance observed in some metabolic disorders
(Shen et al., 2006). Additionally, studies in C. elegans revealed
that decreased DAF-2 insulin-like signaling caused activation
of MAPK, which leads to protein degradation in striated muscle
(Szewczyk et al., 2007). Therefore, although divergent from the
conventional role of MAPK regulation, these findings highlight
the importance of investigating protein regulation and function
from multiple perspectives, and the importance of defining
signaling pathways based on cellular context.
In summary, we have shown that VAB-1, the C. elegans Eph
RTK, and DAF-18/PTEN proteins are substrates for each other
and have mutually antagonistic roles on each other’s function.
Numerous cancer types have been shown to have increased
Eph receptor expression, but the downstream signaling mecha-
nisms are unknown. Our results are significant, as they propose
developmental roles for VAB-1/EphR and DAF-18/PTEN in
C. elegans, and also offer potential avenues for further research
in the mammalian system.
EXPERIMENTAL PROCEDURES
Genetic Analysis
C. elegans strains were cultured as described by Brenner (1974) at 20C unless
otherwise noted. Strains used in this study were as follows: N2 wild-type,
CZ337 vab-1(dx31), RB712 daf-18(ok480), CB1375 daf-18(e1375), IC804
vab-1(dx31);daf-18(ok480), IC218 vab-1(dx31);daf-18(e1375), IC748 quIs18
(genomic rescuing daf-18), IC852 quIs16 [Hs promoter myr::VAB-1];quIs18
[genomic daf-18], BA17 fem-1(hc17), IC745 fem-1 (hc17);vab-1(dx31), IC853
fem-1(hc17);quIs18[genomic daf-18], IC97 mIn1 mIs14/age-1(m333), IC904
vab-1(dx31);daf-16(mu86), and IC902 quIs5[mec-4::myr-VAB-1]; quEx256
[mec-4::daf-18] (Mohamed and Chin-Sang, 2006; this study).
Constructs and Transgenic Lines
To generate the overexpressing DAF-18 strain, quIs18, a 7.8 kb genomic
daf-18 PCR product from wild-type genomic DNA was coinjected with pRF-4
and psur-5::GFP into daf-18(ok480) mutants (all 30 ng/ml). This construct is
able to rescue the daf-18(ok480) dauer and life span phenotype (results not
shown). This line was outcrossed to wild-type to eliminate the daf-18(ok480)
background and then integrated by following a TMP/UV protocol. To generate
the HS MYR::VAB-1(quIs16), we incorporated the c-Src N-terminal myristoy-
lation (MYR) signal (MGSSKS) in a PCR primer to produce a 1.6 kb myr-vab-1
product identical to that used in the quIs5 [mec-4::myr-vab-1] strain
(Mohamed and Chin-Sang, 2006). The myr-vab-1 was cloned into pPD49.83
(A. Fire), a heat-shock vector containing the HS16-41 heat-shock promoter.
This construct was coinjected with HS16-41::GFP and an odr-1::RFP plasmid
(all 30 ng/ml) into N2 worms. Extrachromosomal array lines were obtained, and
a stable chromosomal integration by TMP/UV was used to establish quIs16.All
constructs were verified by sequencing.
Yeast Two-Hybrid Assays
Yeast were grown on standard complete and selective media, as appropriate
(Sherman, 1991). Yeast transformation was performed by using a lithium
acetate method (Schiestl and Gietz, 1989). The 1.6 kb fragment encoding
the kinase domain (669–985 aa) of VAB-1 was amplified from vab-1 cDNA
and cloned into the GAL4 DNA-Binding domain, pAS1, to act as bait in the
C. elegans cDNA library. For deletion analysis, pGBKT7 and pGADT7/pACT
were used as bait and prey cloning vectors, respectively. Primer sequences
and details of plasmid constructs are available upon request.DevelopGST Pull-Down and Copurification Assays
pIC-104, a cDNA encoding the vab-1 intracellular region (581–1117 aa), was
cloned in frame to glutathione-S-transferase (pGEX4T-2, Amersham), and
pIC-263, a vab-1(e2) (G912E) kinase-dead mutation, was created using the
QuikChange Site-Directed Mutagenesis Kits (Stratagene). pIC-73, a cDNA
encoding the DAF-18 Mid region (406–835 aa) was fused in frame to Maltose-
Binding Protein (pMALp2, New England Biolabs). All these fusion constructs
were expressed inE. coli Tuner (DE3). Soluble extract containing MBP::DAF-18
(Load) was incubated for 2 hr at 4C with soluble extract containing either GST
(3 mg/ml), GST::VAB-1, or GST::VAB-1(G912E) (0.25 mg/ml) bound to 40 ml
glutathione resin beads (GST-Bind, Novagen). Unbound fractions were
collected, protein bound to beads was washed four times (25 mM Tris-Cl [pH
7.5], 150 mM NaCl, 1 mM DTT, 10% glycerol, 0.5% Triton X-100), and a propor-
tional loading of each was analyzed by SDS-PAGE followed by western blot.
MBP::DAF-18 was detected by using anti-MBP conjugated to HRP (New
England Biolabs) followed by ECL (Pierce). For the copurification assays,
pIC-582 HIS-6::VAB-1 was coexpressed with either pIC-227 (MBP::DAF-18
full-length WT), pIC-583 (MBP::DAF-18 full-length C169S), or pIC-637 (MBP-
DAF-18 full-length D137A). HIS-6::VAB-1 was purified on nickel resin, and
a portion was run on SDS-PAGE and probed with anti-DAF-18 or MBP to detect
MBP::DAF-18 binding. MBP::DAF-18 (406–835 aa) also copurified with HIS-6::
VAB-1, whereas MBP alone did not (data not shown). The blot was stripped and
reprobed for VAB-1 to show protein levels of purified HIS-6::VAB-1.
Immunohistochemistry
Mixed-Stage Staining
Antibody staining was carried out as described by Chin-Sang et al. (1999).
Anti-GST::DAF-18 and anti-VAB-1:HIS-6 antibodies (rabbit hosts were pro-
duced by Covance, Inc.) were visualized with secondary FITC-anti-rabbit anti-
bodies (Upstate/Millipore).
Gonad Staining
A total of 30–40 L4 larvae were allowed to develop to young adults overnight at
20C. Worm gonads were dissected and placed onto GCP (gelatin, chromium
potassium sulfate, poly-L-lysine)-coated slides, and a coverslip was applied
diagonally and immersed in liquid nitrogen. Slides were then fixed by a meth-
anol/acetone fixation procedure described by Strome and Wood (1983).
Gonads were probed with monoclonal antibody for activated MAP kinase,
Activated (Sigma, M 9692), followed by secondary FITC-anti-mouse anti-
bodies (Chemicon).
Western Blot
Protein lysates were made by plating 10–20 young adults on individual plates
(3 plates per strain); adults were then allowed to lay F1 progeny at 15–20C.
The F1s were bleached to recover embryos (Figures 3A and 3B) or mixed-
stage lysed (Figure 3C) with 23 Sample buffer + DTT, and proteins were sepa-
rated on 10% SDS-PAGE, western blotted, and probed with anti-DAF-18
antibodies and secondary HRP-anti-rabbit antibodies (Upstate/Millipore).
Monoclonal antibodies against actin (Clone C4, MP Biomedicals) were used
as a loading standard, and relative band intensities were calculated by using
the National Institute’s of Health Image J program.
Kinase/Phosphatase Assays
VAB-1 and DAF-18 fusion proteins were coexpressed by using the
pCOLADuet-1 vector system (Novagen) that allows for the inducible expres-
sion of two plasmids within a single E. coli cell. VAB-1 constructs pIC-549
MBP::VAB-1(581–1117 aa) or pIC-551 MBP::VAB-1(G912E) were coex-
pressed with either pIC-227 (MBP::DAF-18 full-length), pIC-73 (MBP::DAF-18
406–835 aa), pIC-583 (MBP::DAF-18 full-length C169S), or pIC-637 (MBP::
DAF-18 full-length D137A). Proteins were induced, and total protein lysates
were run on SDS-PAGE followed by western blot with the anti-phosphotyro-
sine antibody 4G10 (Millipore/Upstate).
RT-PCR
RNA extraction was performed by using the Promega SV Total Isolation
System according to the manufacturer’s protocol. A total of 100 ml of mixed-
stage worm pellet was utilized for each strain. Reverse transcription was
carried out with the New England Biolabs Protoscript II RT-PCR Kit. Region
576–2488 nt was used for daf-18 cDNA amplification.mental Cell 17, 459–469, October 20, 2009 ª2009 Elsevier Inc. 467
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In a procedure adapted from Miller et al. (2001), L4 larvae were picked to plates
and allowed to mature into young adults overnight at 20C. The number of
oocytes/embryos present in the spermatheca/uterus was counted with the
Zeiss Axiovert 200M at 103 magnification. The worms were then allowed to
lay eggs for 5 hr at 20C. The number of eggs retained in the spermatheca/
uterus was counted, as well as the number of eggs laid on the plate. Ovulation
rate was determined by taking the number of eggs retained originally and sub-
tracting it from the number of eggs retained after 5 hr plus the number of eggs
laid during the 5 hr period. The average number of embryos/oocytes ovulated
in 1 hr and per gonad arm was then calculated.
Oocyte and Embryo Counts
Oocyte and embryo counts were performed by picking 6–7 L4 hermaphrodites
as well many individual L4 worms (5–20 individuals for brood profiles; data not
shown) to E. coli seeded plates. Worms were transferred to new seeded plates
every 24 hr for 3 days, and plates were scored for the number of embryos and
oocytes laid. If L1 larvae were present, they were counted as a laid embryo.
The numbers of fertilized eggs and oocytes laid from both multiworm and
individual worm plates were pooled together to give sample size (n).
Dauer Assays: daf-2 RNAi and 27C Experiment
daf-2 RNAi
daf-2 RNAi was generated by cloning a 1.9 kb fragment of daf-2 into the L4440
feeding vector and transforming into HT115(DE3) competent cells. daf-2 RNAi
bacteria was plated out on NGM plates containing Amp (50 mg/ml) and IPTG
(0.4 mM) and was allowed to grow overnight. Strains utilized were synchro-
nized as L1s and then plated onto daf-2 RNAi plates (100/plate) and stored
at 25C. The number of dauer larvae was scored after 48 hr at 25C.
27 Assay
vab-1(dx31), quIs18, and wild-type were synchronized in M9 buffer at 20C,
and L1s were plated onto E. coli seeded plates at 27C. After 48 hr, strains
were scored for dauer versus non-dauer larvae, and the percentages of dauer
formed were calculated as described in Ailion and Thomas (2000).
Life Span Assays
Life span assays were carried out as described by Glenn et al. (2004).
vab-1(dx31) and quIs18 (genomic daf-18) were crossed into a fem-1(hc17)
background to eliminate the need for daily transfers away from progeny.
vab-1(dx31);fem-1(hc17), quIs18;fem-1(hc17), and fem-1(hc17) worms raised
at 15C were synchronized, and L1s were plated out onto E. coli-seeded plates
and then shifted to 25C to develop as females. At L2/L3, ten worms per
seeded plate were picked, and survival was scored every 2 days as a response
to prodding.
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